Page last updated: 2024-08-22

1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea and Aging

1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea has been researched along with Aging in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burger, PC; Green, SB; Hiesiger, EM; Mahaley, MS; Mealey, J; Ransohoff, J; Robertson, JT; Selker, RG; Shapiro, WR; VanGilder, JC1

Trials

1 trial(s) available for 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea and Aging

ArticleYear
Results of a randomized trial comparing intra-arterial cisplatin and intravenous PCNU for the treatment of primary brain tumors in adults: Brain Tumor Cooperative Group trial 8420A.
    Journal of neuro-oncology, 1995, Volume: 25, Issue:2

    Topics: Adult; Aged; Aging; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Cisplatin; Combined Modality Therapy; Disease Progression; Humans; Injections, Intra-Arterial; Injections, Intravenous; Karnofsky Performance Status; Middle Aged; Nitrosourea Compounds; Supratentorial Neoplasms; Survival Analysis

1995